The following table provides an overview of the latest patents of Momenta Pharmaceuticals, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2968549Nov 23, 2022Methods Of Cell Culture2
EP2971040Sep 19, 2018Methods Of Cell Culture10